Kezdőlap Mélykutatási eredmények QA Jelek Területek Módszertan Névjegy Keresés Rákkutatás Publikációk, biológiai célpontok, gyógyszerek, bizonyítékszintek és klinikai vizsgálatok.
A rákkutatási terület evidencialétrát használ a sejtmodelltől a klinikai gyakorlatig. A rendszer kutatási tájékozódást ad, nem diagnosztizál és nem választ kezelést.
Jelek Cervical cancer could be eliminated within a century — Cervical cancerEuropean LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia — Chronic myeloid leukemiaEfficacy, Safety, and Correlative Biomarkers of Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Trial — Nasopharyngeal carcinomaHead and neck squamous cell carcinoma — Head and neck squamous cell carcinomaWaldenström Macroglobulinemia: Clinical Presentation, Diagnosis, and Management — Waldenstrom macroglobulinemiaConvergent and Divergent Signaling Pathways in Cancer: A Dual‑Axis Model for Adaptive Precision Oncology — NSCLCOutcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis — Waldenstrom macroglobulinemiaAdvances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma — Nasopharyngeal carcinomaProjected time to elimination of cervical cancer in the USA: a comparative modelling study — Cervical cancerNivolumab Plus Ipilimumab for Treatment‑Naïve Metastatic Uveal Melanoma: An Open‑Label, Multicenter, Phase II Trial — MelanomaAdrenocortical Carcinoma — Adrenocortical carcinomaCervical cancer: Epidemiology, risk factors and screening — Cervical cancerAdvances in targeted therapy for esophageal cancer — Esophageal cancerImmunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions — MelanomaEffectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia — LymphomaEffect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer — Colorectal cancerLurbinectedin as second‑line treatment for patients with small‑cell lung cancer: a single‑arm, open‑label, phase 2 basket trial — SCLCPrecision Medicine CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer — Breast cancerOverall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. — NSCLCPembrolizumab for Early Triple‑Negative Breast Cancer — Breast cancerElőző 70/102 Következő